IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ONIDA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.866
NA - Nord America 16.026
AS - Asia 14.785
SA - Sud America 1.531
AF - Africa 263
OC - Oceania 137
Continente sconosciuto - Info sul continente non disponibili 27
Totale 57.635
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.434
DE - Germania 8.961
GB - Regno Unito 6.065
CN - Cina 5.198
SG - Singapore 3.945
IT - Italia 2.641
RU - Federazione Russa 1.311
SE - Svezia 1.155
HK - Hong Kong 1.101
BR - Brasile 1.051
FR - Francia 988
VN - Vietnam 820
IN - India 799
BD - Bangladesh 768
ES - Italia 701
UA - Ucraina 670
NL - Olanda 471
JP - Giappone 464
KR - Corea 445
FI - Finlandia 439
TR - Turchia 427
CA - Canada 422
IE - Irlanda 421
EU - Europa 307
CO - Colombia 217
PL - Polonia 189
ID - Indonesia 166
DK - Danimarca 161
AR - Argentina 126
BE - Belgio 124
AT - Austria 118
TW - Taiwan 111
AU - Australia 109
CH - Svizzera 103
MX - Messico 90
CI - Costa d'Avorio 77
GR - Grecia 74
IL - Israele 67
PH - Filippine 64
IQ - Iraq 56
TH - Thailandia 47
UZ - Uzbekistan 45
CZ - Repubblica Ceca 44
SA - Arabia Saudita 44
PT - Portogallo 42
ZA - Sudafrica 40
EC - Ecuador 36
NO - Norvegia 34
PK - Pakistan 33
RO - Romania 33
EG - Egitto 32
CL - Cile 31
NZ - Nuova Zelanda 26
VE - Venezuela 26
DZ - Algeria 22
IR - Iran 21
MA - Marocco 20
MY - Malesia 19
NP - Nepal 19
JO - Giordania 17
TN - Tunisia 17
LB - Libano 16
AE - Emirati Arabi Uniti 15
BG - Bulgaria 15
PE - Perù 15
KE - Kenya 14
CR - Costa Rica 13
LT - Lituania 13
SK - Slovacchia (Repubblica Slovacca) 13
HR - Croazia 11
HU - Ungheria 11
RS - Serbia 11
UY - Uruguay 11
BY - Bielorussia 10
PY - Paraguay 10
HN - Honduras 9
OM - Oman 9
AZ - Azerbaigian 8
GE - Georgia 8
KZ - Kazakistan 8
GT - Guatemala 7
JM - Giamaica 7
LU - Lussemburgo 7
TT - Trinidad e Tobago 7
AL - Albania 6
AM - Armenia 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
LK - Sri Lanka 6
LV - Lettonia 6
CY - Cipro 5
KG - Kirghizistan 5
PA - Panama 5
QA - Qatar 5
SN - Senegal 5
BB - Barbados 4
BW - Botswana 4
ET - Etiopia 4
KW - Kuwait 4
PR - Porto Rico 4
Totale 57.833
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 7.314
Southend 5.263
Singapore 2.120
Ashburn 1.348
Boise 1.203
Beijing 1.090
Hong Kong 970
Dallas 929
Chandler 852
San Jose 777
Seattle 719
Milan 675
Jacksonville 621
Santa Clara 488
Wilmington 468
Princeton 465
Hefei 445
Council Bluffs 427
Dublin 407
Bengaluru 376
Los Angeles 335
Fairfield 299
New York 295
Nanjing 271
Shanghai 265
Lauterbourg 264
Ho Chi Minh City 259
Redmond 247
Munich 239
Hanoi 221
Guangzhou 214
Moscow 205
Woodbridge 204
Helsinki 198
Serra 197
Buffalo 195
Boardman 194
Tokyo 190
Dearborn 185
Mountain View 184
Houston 183
Des Moines 179
Madrid 176
Ann Arbor 174
Bogotá 162
Andover 155
Sakarya 154
Rome 153
Redwood City 147
Toronto 142
São Paulo 134
Hangzhou 129
Tianjin 120
Jinan 112
Mcallen 112
Cambridge 108
The Dalles 104
Barcelona 102
Paris 101
Somerville 101
Montréal 99
Shenyang 99
Berlin 95
Columbus 94
Payette 93
Jakarta 85
Nanchang 84
Chicago 81
Abidjan 77
Cangzhou 75
Taipei 73
Garden Valley 72
Changsha 69
Hebei 67
London 67
Nuremberg 64
Phoenix 64
Shenzhen 63
Turin 62
Naples 59
Warsaw 57
Jerome 56
Vienna 56
Bitonto 53
Lewiston 53
Valencia 52
Orofino 51
Bologna 50
Brussels 50
Zhengzhou 50
Istanbul 49
Athens 48
San Diego 48
Seoul 48
Fuzhou 46
Washington 46
Margão 45
Atlanta 44
Florence 44
Pisa 44
Totale 36.898
Salva come PNG Salva come JPEG
Nome #
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations 1.734
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome : A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial) 1.326
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial 1.192
Acquired in-vitro resistance to STI571 (Imatinib mesylate) in BCR/ABL-positive cell lines: investigation of gene expression by molecular pathway microarrays 926
In-vitro effects of STI571 (Imatinib mesylate) in BCR/ABL-positive cell lines : modulation of gene expression assessed by pathway microarrays 911
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee 841
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial 761
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review 699
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies 652
Autologous hematopoetic stem cell transplantation for refractory Crohn disease a randomized clinical trial 536
Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's Disease : a review on behalf of ECCO and EBMT 509
RAS mutations vontribute to evolution of chronic myelomonocytic leukemia to the proliferative variant 471
Single institution retrospective analysis of bronchoalveolar lavage as etiological diagnostic tool for pulmonary infiltrates in patients with haematological malignancies 466
Upfront treatment of mantle cell lymphoma by sequential high dose immunochemotherapy supported by in vivo-purged stem cell double autologous transplantation : a single institution experience 394
Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution. 359
Trapianto autologo di cellule staminali (HSCT) in paziente con mieloma multiplo e danno renale in dialisi peritoneale: esempio di un’efficace gestione multidisciplinare 357
Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT 352
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 349
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 339
TCRbeta Gene Rearrangements for Detection and Monitoring of Minimal Residual Disease after Allogenic Stem-Cell Transplantation in Patients with Advanced Mycosis Fungoides and Sézary Syndrome 337
Long-term clinical and molecular outcomes following RIC-allogeneic HSCT from HLA-identical sibling in patients with advanced mycosis fungoides and Sézary syndrome 334
Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn's disease 334
Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT 332
Activity of sphingosine kinase inhibitor in Chronic Myelogenous Leukemia cells sensitive and resistant to Imatinib Mesylate 329
Allogeneic hematopoietic stem cell transplantation for MDS and CMML : recommendations from an international expert panel 321
Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease 311
Indolent B-cell lymphomas treated upfront with antiviral therapy : a series of 13 patients 307
Autologous haematopoietic stem cell transplantation for Crohn's disease : a retrospective survey of long-term outcomes from the European Society for Blood and Marrow Transplantation 306
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up without CD34+ cell selection 293
Proposed diagnostic criteria for classical CMML, CMML variants and pre-CMML conditions 282
Impact of Cytogenetics on Outcome of Patients with MDS or Secondary AML Undergoing Allogeneic HSCT from HLA-identical Siblings : a Retrospective Analysis of the EBMT-CLWP 281
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up with unselected stem cells 281
Metalloproteinase alterations in the bone marrow of ALS patients 273
Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant from the Same Donor with No Immunosuppression but C5 Inhibition 270
Retrospective analysis of salvage regimen for relapsed or refractory classical Hodgkin lymphoma 269
L’infezione da CMV refrattaria nella fase post-trapianto: inquadramento epidemiologico nel contesto italiano, attuale gestione del paziente e unmet need : Refractory CMV infection in post-transplant phase: epidemiological framing in the Italian context, current patient management and unmet needs 265
Evolving pattern of microbial susceptibility to antibiotics in a HSCT unit 264
Array-based comparative genomic hybridization analysis of aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma (AECD8+L), extranodal NK/T nasal type lymphoma (ENK/T-NT) and blastic plasmocytoid dendritic cell neoplasia (BPDCN) 262
Evaluation of deoxycholate amphotericin-B toxicity after HSCT 258
Analisys of bone marrow hematopoietic and mesenchymal precursors in patients with amyotrophic lateral sclerosis 255
Evidence of graft-versus-leukaemia following allogeneic haematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome 254
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet 254
La formazione pre-laurea sulle cure palliative presso l'Università degli Studi di Milano 252
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome : a study from the Gruppo Italiano Trapianto di Midollo Osseo(GITMO) 251
Analysis of T-cell receptor rearrangements and microarrays in pediatric patients with cutaneous lymphoma 251
Chronic myelomonocytic leukemia : identification of molecular abnormalities and monitoring of ras mutations-driven disease progression by allele-specific PCR 250
Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies 249
Functional alteration of bone marrow mesenchymal stem cells of Amyotrophic Lateral Sclerosis Patients 247
Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients 246
Isolation and characterization of L-NGFR(+) mesenchymal stem cells from adipose tissue and bone marrow: a comparison between the two sources 242
Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report 238
A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin 238
Evolution of empirical antifungal therapy in a bone marrow transplantation unit 234
Amyotrophic Lateral Sclerosis Bone Marrow Characterization 232
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 232
Human bone marrow mesenchymal stem cells transplantation in 6-hydroxydopamine-lesioned rodents 231
Non-myeloablative allografting for newly diagnosed multiple myeloma : the experience of the Gruppo Italiano Trapianti di Midollo. 229
Autologous haematopoietic unselected peripheral blood stem cell transplantation in refractory Crohn's disease: up to 2-years follow-up of a phase I-II trial 227
Reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sézary syndrome 225
Comparison of Allogeneic Stem Cell Transplantation and Non-Transplant Approaches in Elderly Patients with Advanced Myelodysplastic Syndrome : Optimal Statistical Approaches and a Critical Appraisal of Clinical Results Using Non-Randomized Data 225
Autologous hematopoietic stem cell transplantation : a successful treatment for early severe systemic sclerosis 223
In vitro anti-leukaemia activity of sphingosine kinase inhibitor 223
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B-Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial Including Rituximab in the Reduced Intensity Conditioning Regimen 221
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma 220
Second malignancies in essential thrombocytosis: a retrospective analysis of 331 patients from a single institution (Abs. P351) 220
PRO-APOPTOTIC EFFECT OF A NEW SMAC-MIMETIC ON B-CLL CELLS IN VITRO 220
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD34+ cells selection 218
Autologous haematopoietic stem cell transplantation for refractory Crohn’s disease: updating the Milan experience without CD34+ cell selection 218
High Frequency of Tumor Suppressor Genes Promoter Hypermethylation in Peripheral Blood of Patients with Myelodysplastic Syndromes 217
Autologous non- myeloablative haematopoietic stem cell transplantation without CD34+selection for refractory Crohn's disease: the Milan experience after 5 years 216
Biological and molecular differences between the dysplastic and the proliferative variants of chronic myelomonocytic leukemia 215
Mesenchymal stem cells fron bone marrow of patients with Systemic Sclerosis : properties and pathogenic perspectives 215
Bortezomib (Velcade)-thalidomide-dexamethasone (VTD) is superior to thalidomide-dexamethasone (TD) in patients with multiple myeloma (MM) progressing or relapsing after autologous transplantation 214
Biological characterization of hematopoietic and mesenchymal stem cell compartments in sporadic Amyotrophic Lateral Sclerosis 213
Hyperleptinaemia in long-term transplant survivors with metabolic syndrome 213
Incidence and predictive factors of hepatic veno-occlusive disease after bone marrow transplantation 212
In vitro effect of second mitochondria-derived activator of caspases (SMAC) mimic compounds on myeloid leukemia cell lines 211
Pegylated G-CSF after autologous hematopoietic stem cell transplantation 210
Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) versus Thalidomide-Dexamethasone to treat multiple myeloma (MM) patients progressing or relapsing after autologous transplantation : the MMVAR trial, a study from the myeloma subcommittee of the Chronic Leukemia Working Party of the EBMT 210
Metabolic syndrome in patients with hematological diseases 210
Single-agent Smac-mimetic compounds induce apoptosis in B chronic lymphocytic leukaemia (B-CLL) 210
Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir 209
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion : a retrospective European Group for Blood and Marrow Transplantation analysis 208
Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells : mechanistic studies of Smac mimetic 207
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas 206
Diagnosis and Management of Chronic Myelomonocytic Leukemia 205
Unrelated mismatched cord blood transplantation in an adult with secondary AML 203
Retrospective evaluation of amphotericin B deoxycholate toxicity in a single centre series of haematopoietic stem cell transplantation recipients 203
Autologous stem cell transplantation in Crohn's disease 201
Autologous hematopoietic stem cell transplantation in early severe systemic sclerosis 201
Allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia with 17p Deletion: a retrospective EBMT analysis. 200
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R 200
Autologous stem cell transplantation in moderate-severe refractory Crohn's disease : the Milan experience without CD34+ cells selection 199
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide 199
Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma 198
Sphingosine kinase 1 as a potential target to inhibit proliferation of myeloid leukemia cells 198
Sphingolipids players in the leukemia arena 198
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01 197
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD 34+ cells selection 197
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) 197
Totale 32.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.154
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.154
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021185 0 0 0 0 0 0 0 0 0 0 0 185
2021/20222.341 177 96 110 117 147 132 268 170 300 218 106 500
2022/20233.113 388 256 248 287 414 610 87 211 285 59 146 122
2023/20247.272 93 197 150 189 553 348 991 905 434 977 1.161 1.274
2024/20259.830 1.114 1.102 1.037 1.056 556 353 427 814 480 631 666 1.594
2025/202617.008 1.545 1.565 1.939 1.375 1.306 1.029 1.569 927 1.661 1.409 1.454 1.229
Totale 59.955